Show Notes
With the SARS-CoV-2 Inhibition by Hybrid Graphene Nanoplatelet/Metal Oxide Powders announcement, Share Talk spoke with CEO, Neill Ricketts.
Versarien Plc (AIM: VRS), the advanced materials engineering group, announced the receipt of an independent report (the "Report") produced by Ankara University, Turkey, detailing the results of a preliminary study of modified graphene materials provided by Versarien for use against SARS-CoV-2, the strain of coronavirus that causes coronavirus disease 2019, COVID-19.
The Report concludes that the preliminary test results show that these materials significantly inhibit viral infection and possess anti-viral activity towards SARS-CoV-2.
https://www.share-talk.com/neill-ricketts-ceo-of-versarien-plc-vrs-l-interview/
https://www.share-talk.com/neill-ricketts-ceo-of-versarien-plc-vrs-l-interview/
Listen On
Also Listen
-
Altona Rare Earths PLC (LON:REE) Dr Cedric Simonet spoke with Share Talk
Share Talk interviews Cédric Simonet, CEO of Altona Rare Earths (LON: REE), to d -
Zak Mir talking to Eddie Wyvill, head of Corporate Development – Amaroq Minerals Ltd.
Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine dev -
Zak Mir talking with Nick Tulloch, Chief Executive Officer of Mendell Helium
Zak Mir interviewed Mendell Helium CEO Nick Tulloch regarding M3Helium's new far -
ECR Minerals (AIM:ECR) Chairman Nick Tulloch, MD Mike Whitlow, Technical Consultant Mike Parker and Director Andrew Scott
ECR Minerals, a gold exploration company with assets in Australia, is making sig